The Generic Pharmaceuticals Contract Manufacturing market size is expected to reach $93.56 billion in 2030 at a CAGR of 6.9%, driven by rising demand for biosimilars.
Read More
The Generic Pharmaceuticals market size is expected to reach $588.24 billion in 2030 at a CAGR of 6.7%, driven by increasing incidence of chronic diseases.
Read More
The Generic Oncology Drugs market size is expected to reach $39.99 billion in 2030 at a CAGR of 7.0%, driven by significant rise in cancer patients.
Read More
The Generic Musculoskeletal Disorders Drugs market size is expected to reach $0.09 billion in 2030 at a CAGR of 6.9%, driven by increasing adoption of telemedicine.
Read More
The Generic Injectables market size is expected to reach $267.93 billion in 2030 at a CAGR of 13.7%, driven by rising prevalence of cancer and cardiovascular diseases.
Read More
The Generic Central Nervous System Drugs market size is expected to reach $132.44 billion in 2030 at a CAGR of 7.2%, driven by rising incidence of mental health disorders.
Read More
The General Anesthesia Drugs market size is expected to reach $6.16 billion in 2030 at a CAGR of 3.6%, driven by increasing volume of surgical procedures.
Read More
The Gene-Editing Transfection Chemicals market size is expected to reach $1.56 billion in 2030 at a CAGR of 7.7%, driven by accelerated research in gene therapy.
Read More
The Gene-Circuit Cell Therapy market size is expected to reach $3.56 billion in 2030 at a CAGR of 20.8%, driven by growing adoption of personalized medicine.
Read More
The Gene Therapy on Neurological Diseases market size is expected to reach $6.48 billion in 2030 at a CAGR of 12.7%, driven by rising neurological disorder prevalence.
Read More